mBC Treatment Research Announcement

Share

$200K in New Funding: Breast Cancer Canada Matched Grant

Breast Cancer Canada and AstraZeneca Canada launched new matched grant funding opportunity for research dedicated to improving treatment options for metastatic breast cancer. 

The 2025 call for grants: “Uncovering Predictive Markers and Mechanisms of Treatment Resistance in Advanced HR+ and HER2+ Breast Cancer” opened this summer with the opportunity for two $100,000 awards for Canadian research labs.

At BCC’s Canadian Night at ESMO 2025, the selected research recipients were announced. 

 

 

 

Related Articles

Meet the Researcher: Yubing Xia

My research focuses on HER2-positive breast cancer, a type of breast cancer that is treated with a targeted drug called trastuzumab before surgery. I am

Innovation and Progress in 2026

From more targeted treatments to new ways of monitoring cancer and improving care, research is changing what is possible in breast cancer. Breast cancer research

Progress Through Research

Latest Research

Breast Cancer Canada donations fund life-saving research that directly impacts Canadian patients. That means better answers, bigger breakthroughs – and more personalized treatment for every breast cancer diagnosis.

Patient Tools

Our suite of digital tools are each designed to help individuals better manage their breast cancer journey through education, research and personalized insights, while also elevating the patient voice.

Patient Stories

Every breast cancer journey is unique, but together, these stories paint a powerful picture of progress. Through firsthand accounts from patients and survivors, we share stories that highlight the lived-experiences of breast cancer.

Fuel Progress

Progress happens when we invest in it. Canada is home to some of the world’s brightest minds in research. Together, we are advancing science, ensuring it leads to earlier detection, better treatments, and improved outcomes for patients across the country.

Sign Up, Know More